Efficacy of Postoperative 5-FU, High-Dose Leucovorin, and Sequential Radiation Therapy for Clinically Resectable Rectal Cancer

References

• Fisher B, Wolmark N, Rockette H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21–29
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465–1472
   PubMed Web of Science ®Google Scholar
• Douglass H O, Moertel C G, Mayer R J. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986; 315: 1294–1295
   PubMed Web of Science ®Google Scholar
• Krook J E, Moertel C G, Gunderson L L. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709–715
   PubMed Web of Science ®Google Scholar
• Erlichman C, Fine S, Wong A. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988; 6: 469–475
   PubMed Web of Science ®Google Scholar
• Doroshaw J H, Multhauf Leong P. L. Prospective randomized comparison of fluorouracil versus fluorouracil and high dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990; 8: 491–501
   PubMed Web of Science ®Google Scholar
• Petrelli N, Herrera L, Rustum Y. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-tluorouracil and methotrexate in previously untreated patients with advanced colorectal cancer. J Clin Oncol 1987; 5: 1559–1565
   PubMed Web of Science ®Google Scholar
• O'Connell M J. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group Study. Cancer 1989; 63: 1026–1030
   PubMed Web of Science ®Google Scholar
• Valone F H, Friedman M A, Wittlinger P S. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil. or sequential methotrexate, fluorouracil and leucovorin: A randomized trial of the Northern California Oncology Group. J Clin Oncol 1989; 7: 1427–1436
   PubMed Web of Science ®Google Scholar
• Petrelli N, Douglass HO, Jr., Herrera L. The modulation of tluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 1989; 7: 1419–1426
   PubMed Web of Science ®Google Scholar
• Nobile M, Canobbio L, Sobrero A. A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients. The Expanding Role of Folates and Fluoropyrimidined in Cancer Chemotherapy: Advances in Experimental Medicine and Biology, Y Rustum, J McGuire. Plenum Press, New York 1988; 213–218
   Google Scholar
• Minsky B, Cohen A, Enker W. Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer. Int J Radiat Oncol Biol Phys 1992; 22: 139–145
   PubMed Web of Science ®Google Scholar
• Minsky B D, Cohen A M, Enker W E. Combined modality therapy of rectal cancer: Decreased acute toxicity with the pre-operative approach. J Clin Oncol 1992; 10: 1218–1224
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. Handbook for Staging Cancer, 4th ed. JB Lippincott, Philadelphia 1993; 95–102
   Google Scholar
• Cohen A M, Minsky B D. A phase 1 trial of preoperative radiation, proctectomy. and endoanal reconstruction. Arch Surg 1990; 125: 247–251
   PubMed Web of Science ®Google Scholar
• Minsky B D, Cohen AM., Enker W E. Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys 1992; 23: 387–392
   PubMed Web of Science ®Google Scholar
• Minsky BD., Cohen A M, Enker W E. Sphincter preservation in rectal cancer by local excision and postoperative radiation therapy. Cancer 1991; 67: 908–914
   PubMed Web of Science ®Google Scholar
• Minsky B D. Pelvic radiation therapy in rectal cancer: Technical considerations. Semin Radiat Oncol 1993; 3: 42–47
   PubMedGoogle Scholar
• Anderson LL., Osian A D. Brachytherapy optimization and evaluation. Endocurie Hypertherm Oncol 1986; 2: S25–S32
   Google Scholar
• Goldstein A. Biostatistics: An Introductory Text. Macmillan, New York 1971
   Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation for incomplete observation. J Am Statist Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Machover D, Schwarzenberg Goldschmidt L. E. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: A pilot study. Cancer Treat Rep 1982; 66: 1803–1807
   PubMedGoogle Scholar
• Poon MA, O'Connell MJ., Wieand H S. Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991; 9: 1967–1972
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992; 10: 549–557
   PubMed Web of Science ®Google Scholar
• Minsky B, Kemeny D. N., Cohen A M. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991; 67: 2859–2866
   PubMed Web of Science ®Google Scholar
• Minsky BD., Cohen A M, Kemeny N. Pre-operative combined 5-FU. low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1993; 25: 821–827
   PubMed Web of Science ®Google Scholar
• Minsky B, Cohen A, Enker W. Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 1994; 73: 273–278
   PubMed Web of Science ®Google Scholar